ATXN1 | Ataxin 1 | Disease related genes
| | | | | Expressed in all |
ATXN10 | Ataxin 10 | Disease related genes
| | | | | Expressed in all |
ATXN2 | Ataxin 2 | Disease related genes
| | | | | Expressed in all |
ATXN3 | Ataxin 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATXN7 | Ataxin 7 | Disease related genes Plasma proteins
| | | | | Expressed in all |
AUH | AU RNA binding protein/enoyl-CoA hydratase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
B3GALNT2 | Beta-1,3-N-acetylgalactosaminyltransferase 2 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
B3GNT1 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B4GALT7 | Xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BAAT | Bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
BAG3 | BCL2-associated athanogene 3 | Disease related genes Plasma proteins
| | | | | Expressed in all |
BANF1 | Barrier to autointegration factor 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes
| | | | | Tissue enhanced |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BAZ1B | Bromodomain adjacent to zinc finger domain, 1B | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
BBS4 | Bardet-Biedl syndrome 4 | Disease related genes
| | | | | Expressed in all |
BBS7 | Bardet-Biedl syndrome 7 | Disease related genes Plasma proteins
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCKDHB | Branched chain keto acid dehydrogenase E1, beta polypeptide | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
BCKDK | Branched chain ketoacid dehydrogenase kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BCL3 | B-cell CLL/lymphoma 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
BCL7A | B-cell CLL/lymphoma 7A | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BCS1L | BC1 (ubiquinol-cytochrome c reductase) synthesis-like | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
BFSP1 | Beaded filament structural protein 1, filensin | Disease related genes
| | | | | Mixed |
BICC1 | Bicaudal C homolog 1 (Drosophila) | Disease related genes
| | | | | Tissue enhanced |
BICD2 | Bicaudal D homolog 2 (Drosophila) | Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
BLNK | B-cell linker | Disease related genes
| | | | | Mixed |
BLOC1S6 | Biogenesis of lysosomal organelles complex-1, subunit 6, pallidin | Disease related genes
| | | | | Expressed in all |
BPGM | 2,3-bisphosphoglycerate mutase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes
| | | | | Mixed |
BRCC3 | BRCA1/BRCA2-containing complex, subunit 3 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
BSND | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |